The disintegration tester market has seen considerable growth due to a variety of factors.
• The market size of the disintegration tester has exhibited robust growth in the past few years. Projected to expand from $103.09 billion in 2024 to $110.58 billion in 2025, it will witness a compound annual growth rate (CAGR) of 7.3%.
The previous expansion can be linked to various factors such as the escalation in the count of automatic disintegration tests, the expansion of the pharmaceutical sector, heightened investments in research and development, an increasing mandate for regulatory compliance and quality assurance, a surge in healthcare spending, and an enhanced emphasis on quality control.
The disintegration tester market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations indicate a robust growth trend for the disintegration tester market in the upcoming years. Its value is projected to reach $145.32 billion by 2029, expanding at a compound annual growth rate (CAGR) of 7.1%.
The growth drivers during this forecast period are largely due to an increased prevalence of chronic diseases, expanding customer health consciousness, surge in the production of generic drugs, heightened focus on quality control in pharmaceutical manufacturing, and a growing demand for automated processes. Key trends anticipated during this forecast period encompass product innovation, progressions in pharmaceutical technology, digital technology integration, breakthroughs in in-line testing techniques, and incorporation of internet of things (IoT).
The anticipated growth of the disintegration tester market is closely tied with the expansion of the pharmaceutical industry. This segment focuses on various aspects including research, development, manufacturing, and distribution of medicinal drugs intended for disease prevention, diagnosis, treatment, and eradication. The expansion of pharmaceutical industries is catalyzed by a range of influences such as an aging demographic, increased incidences of chronic ailments, medical technology advancements, expanded healthcare accessibility, and rising health and wellness consciousness. The disintegration tester is imperative within this industry, as it measures the time a solid dosage form like a tablet or capsule, takes to disintegrate into smaller fragments when subjected to specific fluids under regulated conditions, mirroring the human gastrointestinal environment. For instance, data from the Government of Canada administration in August 2024 indicates that domestic exports in the pharmaceutical trade escalated to 12.79 in 2022, up from 10.71 in 2021, with imports enlarging to 30.21 in 2022 from 26.63 in 2021. Consequently, the growth of the pharmaceutical sector is fuelling the expansion of the disintegration tester market.
The disintegration testermarket covered in this report is segmented –
1) By Type: 2 Station Disintegration Tester, 4 Station Disintegration Tester, 6 Station Disintegration Tester, Other Types
2) By Distribution Channel: Direct Sales, Distributors, Online Retail
3) By Application: Pharmaceutical Industry, Cosmetics Industry, Food Industry, Other Applications
Subsegments:
1) By 2 Station Disintegration Tester: Manual 2 Station Tester, Automated 2 Station Tester
2) By 4 Station Disintegration Tester: Manual 4 Station Tester, Automated 4 Station Tester
3) By 6 Station Disintegration Tester: Manual 6 Station Tester, Automated 6 Station Tester
4) By Other Types: Disintegration Tester with Temperature Control, Disintegration Tester With Optical Sensors, Multi-Station Disintegration Tester
Key players in the disintegration tester market are concentrating on the creation of innovative products like the digital high-volume dissolution tester and the cable-free disintegration baskets. The digital high-volume dissolution tester is a lab appliance that calculates the dissolution rate of a drug in a controlled environment and in a specific solvent. Cable-free disintegration on the other hand, is a basket used in the pharmaceutical sector to measure the speed at which a capsule or tablet degrades into smaller pieces in a fluid; this is vital for evaluating drug release. For example, in January 2022, ERWEKA GmbH, a German disintegration testers producer, introduced the DT 9510 and the ZT 730, these are a digital high-volume dissolution tester and a cable-free disintegration basket respectively. The DT 9510 is known as the pioneer in digital high-volume dissolution testers specifically designed for accurate and efficient testing. It incorporates an airlift mechanism that enables motorized dissolution head lifting and lowering. The ZT 730, which is the first-ever cable-free disintegration tester, harnesses air-basket technology and has a special design that excludes cables, thereby making it easy to set up and operate. The DT 9510 is also equipped with an automated disintegration time detection feature that uses sensor systems to automatically identify the disintegration time.
Major companies operating in the disintegration tester market are:
• Agilent Technologies Inc.
• MRC Group
• Veego Instruments
• Sotax Corporation
• Labindia Analytical Instruments Private Limited
• Kerone Engineering Solutions Ltd.
• Torontech Inc.
• Distek Inc.
• Koehler Instrument Company.Inc.
• Veego Instrument Corporation
• Saintyco
• Kinesis Inc.
• Copley Scientific Limited
• Pharma Test Apparatebau AG
• Yatherm Scientific
• Charles Ischi AG
• Pharmatron LLC
• ATS Scientific Inc.
• Electrolab Group
• Vedor Group
Asia-Pacific was the largest region in the disintegration tester market in 2024. The regions covered in the disintegration tester market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.